Mucins in the Diagnosis and Differential Diagnosis of Pancreatic Cystic Neoplasms: Report of 40 Cases
Ji Yuan,Tan Yun-shan,Xu Jian-fang,Qi Wei-dong,Li Xiao-ping,Su-Jie Ake-Su,Zhu Xiong-zeng
DOI: https://doi.org/10.1097/00029330-200605010-00011
2006-01-01
Abstract:Cystic neoplasms of the pancreas account for 10% to 15% of all cystic pancreatic lesions. The majority (85% to 90%) of cystic lesions of the pancreas are pseudocysts. Although cystic neoplasms of the pancreas are rare, they range from benign to malignant neoplasms. The clinical challenge is the differential diagnosis and management of the cystic neoplasms, which represent 10% to 25% of primary pancreatic neoplasms. Pancreatic neoplasms and tumour like lesions with cystic features have been recently reviewed. The incidence of pancreatic cystic neoplasms reported is variable. Because there is no large, systematic study on tne cases from China comparing the incidence and biology of cystic neoplasms of pancreas to that of Western series, we reviewed all the cases of cystic neoplasms from Zhongshan Hospital over 6 years. Most of the neoplasms in our series were classified according to the recent World Health Organization (WHO) classification.1,2 Mucins are a group of high relative molecular mass glycoproteins that are widely expressed in epithelial cells.3 Malignant transformation of epithelial cells is generally associated with the abnormal glycosylation of mucins. In the present study, we examined the expression of the well characterized mucins (MUC1, MUC2, MUC4, MUC5AC, and MUC6) in cystic neoplasms of pancreas. The goal was to identify the mucin profile, which is a specific marker in the differential diagnosis of pancreatic cystic neoplasms. METHODS Forty cases were collected from the pathological files from January 1999 to December 2004 at Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai. The diagnoses of these neoplasms were based on the WHO classification. This series of cases, included 12 serous cystic neoplasms (SCNs), 10 mucinous cystic neoplasms (MCNs), 9 pseudopapillary neoplasms (SPNs), 7 intraductal papillary mucinous neoplasms (IPMNs), and one each of ductal adenocarcinoma and neuroendocrine tumour with cystic change. Clinical information was obtained from the patient records or the clinician in charge. In most patients, the tumours were removed surgically. All specimens were fixed in buffered formalin and embedded in paraffin. Deparaffinized sections were stained with haematoxylin/eosin and periodic acid/schiff. Immunohistochemical analysis was carried out on serial sections cut from the cystic epithelial neoplasms using the Envision (DAKO, Carpiteria, CA) method. RESULTS Serous cystic neoplasms The most common type in thes series was serous cystadenoma (30%), which is characterized by a central stellate scar, sharp demarcation from surrounding pancreatic tissues and predominant occurrence in women. The tumour is composed of cuboidal or flattened epithelial cells with clear to pale cytoplasm and a small oval nucleus. A single layer of these cells lined the cyst and produced serous fluid. Of the various mucins tested, MUC1 (75%) and MUC6 (66%) had the highest positive rates (Table. 1). MUC2 stained only 8.3% of SCNs, and MUC5AC staining was completely lacking. In normal pancreatic tissue surrounding the tumour, small duct cells and centroacinar cells showed apical positive for MUC6 and MUC1. (Fig. 1)Table 1: Mucin profile of pancreatic cystic neoplasmsFig.1.: MUC6 was expressed in the cystic wall of seruous cystic neoplasms, which is composed of cuboidal or flattened epitheial cells with clear to pale cytoplasm and a small oval nucleus.Mucinous cystic neoplasms There were 10 MCNs presented as large round cystic masses with a unilocular or multilocular cut surface. Microscopically, the cysts were lined by mucin producing, epithelial cells with variant degree of dysplasia, supported by an ovarian like stroma. Of the MCNs, 7 were classified as adenomas, 1 as borderline tumour, and 2 as carcinomas with invasive component. MUC1 was positive only in the invasive components of carcinomas. All of the MCNs were negative for MUC2, except for goblet cells, which were quite numerous in borderline and carcinomas but rare in adenomas. MUC5AC expression was found in all MCNs (Fig. 2). The cytoplasmic staining intensity increased with progressive nuclear atypia and was strongest in the invasive carcinomas. A few cells stained faintly for MUC6.Fig: 2. MUC5AC was expressed in cytoplasm of mucin-producing epithelial cells with variant degree of dysplasia, supported by an ovarian-like stroma.Intraductal papillary mucinous neoplasms Among the 7 patients, 5 had the main pancreatic duct type, and 2 had the branch type. On histological analysis of the entire resection specimen, IPMN showed simple hyperplasia (adenoma) in 2 patients, atypical hyperplasia (borderline lesion) in 1, in situ carcinoma in 1, and invasive carcinoma in 3. In all patients, the epithelial proliferative lesion involving the main or secondary pancreatic duct showed a papillary structure. Immunochemically, 5 were classified as intestinal type (MUC1 –, MUC2+, Fig. 3), and 2 as pancreaticobiliary type (MUC1+, MUC2-). Of the 3 IPMNs with invasive carcinoma, the invasive component showed the features of either a mucinous (colloid) or ductal carcinoma with MUC1+. The mucin profiles of the mucinous or ductal component corresponded to the intestinal or pancreaticobiliary type respectively.Fig: 3. MUC2 was stained in the intestinal type epithelial cells which showed a papillary architecture in intraductal papillary mucinons neoplasms.Solid pseudopapillary neoplasms In the 9 SPNs, the extent of the cystic changes varied from part of the tumour to almost the entire tumour tissue. Microscopically, the SPN showed solid areas composed of polygonal epithelioid cells, with minimal intervening stroma, accompanied by numerous, capillary sized vessels. Some areas showed more extensive stromal fibrosis, with round aggregates of perivascular, hyalinized stroma giving a cylindrical appearance. In the pseudopapillary regions, the cells located away from the small vessels appeared to have dropped away, leaving an irregular cuff of cells surrounding each vascular core. Immunohistochemical studies revealed that SPNs showed a consistent pattern of reaction with vimentin, α-1-antitrypsin (α-1-AT) and α-1-antichemotrypsin (α-1-ACT), and infrequently, generally focal positive for cytokeratin and S-100 protein. None was reactive for mucins or pancreatic hormones. Positive β-catenin and progesterone receptor interactions were limited to the nuclei of tumour cells. Cystic ductal adenocarcinoma MUC1 was detected in invasive component. The staining of MUC5AC was focal and did not exceed 30% of the tumour. MUC2 was absent. Cystic neuroendocrine tumours As the typical neuroendocrine tumour (NET) without cystic change, this case showed tissues tissues diffuse stained for SYN, CHG-A and NSE, as well as pancreatic hormone, glucagons, but negative for all mucins. Our results demonstrated that MCNs, IPMNs and DACs expressed different mucin glycoprotein, and their mucin expression profiles may serve as an additional classification feature. (Table. 2)Table 2: Diagnostic features of pancreatic cystic neoplasmsDISCUSSION Owing to improved recognition and resectability, an increasing number of cystic pancreatic neoplasms have been identified in several institutions. Our series of 40 cystic neoplasms of pancreas, which included all of the WHO mentioned entities with exception of the acinar cell cystadenocarcinoma and acinar cell cystadenoma, accounted for 20%, if we consider only the cystic neoplasms and calculated their relative frequency among the primary neoplasms of pancreas. The clinical challenge is the differential diagnosis and management of cystic neoplasm, which represent a wide range of biologic behaviours. A variety of biochemical, genetic, and imaging techniques have been developed for diagnostic purposes and/or for monitoring the outcome of cystic neoplasms of the pancreas. In consideration of the potentials and limitations inherent in each of these methods, the need for efficient differential diagnostic markers that specifically discriminate pancreatic adenocarcinoma cannot be overemphasized. In this regard, mucins are candidates for such a purpose, with respect to their biochemical properties correlating with malignant conditions.4 Recent studies have demonstrated the association of a deregulated expression of mucins with various types of malignancies. Our study revealed SCNs exhibiting a similar, if not, identical immunoprofile positive for MUC1 and MUC6, whereas none of the SCNs expressed MUC5AC, although mucin production is not a histological feature of SCNs. The mucin profile of SCNs that were positive for MUC6 supports the hypothesis of a direction of differentiation toward centroacinar cells, especially since other investigators have shown that the ultrastructural features of the tumour cells are similar to those of centroacinar cells.5 MCNs progress through stages of increasing dysplasia, from mucinous cystadenoma to borderline mucinous cystic neoplasm to mucinous cystic neoplasm with in situ carcinoma, finally to reach the stage of invasive adenocarcinoma. Noninvasive MCNs, regardless of the degree of cellular atypia, were all positive for MUC5AC and negative for MUC1. Only in cases with an invasive component was MUC1 expression observed. MUC2 perinuclear expression was restricted to goblet cells scattered within the epithelium of MCN and was often accompanied by endocrine cells, a further indication of intestinal differentiation. IPMNs are mucinous, often villous, neoplasms of the pancreas that grow within the larger existing ducts of the pancreas and do not contain ovarian like stroma. The main difference between ductal adenocarcinomas (DAC) and IPMNs is an increased expression of MUC2 associated with a decreased expression of MUC1 in IPMN vs DAC. In both cases, MUC4 was highly expressed. MUC2 and MUC5AC levels were shown to be very high in IPMNs compared with DACs. MCNs, IPMNs and DAC (pancreatic intraepithelial neoplasims) share a columnar mucin producing cell type, which might suggest that they have a common origin. The neoplastic cells of SPNs composed of relatively monomorphous cells of uncertain lineage or histogenesis6 are consistently immunopositive for vimentin and α-1-AT but negative for mucins. Cystic neuroendocrine tumour is easy to be distinguished from other epithelial cystic neoplasms by the lack of mucin expression and presence of neuroendocrine markers.7 In summary, mucin profile may lead not only to the earlier diagnosis of pancreatic tumours but also to the correct diagnosis of these neoplasms. Mucin alteration may, in conjunction with histological study, provide important information on tumour type and thus on patient treatment and prognosis.